Rinat Ariely

1.6k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Rinat Ariely is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rinat Ariely has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rinat Ariely's work include Asthma and respiratory diseases (7 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Medication Adherence and Compliance (4 papers). Rinat Ariely is often cited by papers focused on Asthma and respiratory diseases (7 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Medication Adherence and Compliance (4 papers). Rinat Ariely collaborates with scholars based in United States, United Kingdom and Switzerland. Rinat Ariely's co-authors include Cyrus Cooper, Tjeerd van Staa, Bo Abrahamsen, Melvin Olson, Anna O. D’Souza, Joseph Doyle, Lesley-Ann Miller, Michael J. Smith, Elizabeth Unni and Michael Schätz and has published in prestigious journals such as Neurology, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Rinat Ariely

25 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Excess mortality following hip fracture: a systematic epidemiological review

2009 828 citations Bo Abrahamsen, Tjeerd van Staa et al. Osteoporosis International profile →

Peers

Countries citing papers authored by Rinat Ariely

Since Specialization

Citations

This map shows the geographic impact of Rinat Ariely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rinat Ariely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rinat Ariely more than expected).

Fields of papers citing papers by Rinat Ariely

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rinat Ariely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rinat Ariely. The network helps show where Rinat Ariely may publish in the future.

Co-authorship network of co-authors of Rinat Ariely

This figure shows the co-authorship network connecting the top 25 collaborators of Rinat Ariely. A scholar is included among the top collaborators of Rinat Ariely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rinat Ariely. Rinat Ariely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study 2021 ·Leukemia Research ·Ali McBride, Shoshana Daniel, Maurice T. Driessen, Ágota Szende, (unknown), (unknown), Rinat Ariely, Stephen Thompson	6
2	US Real-world Migraine-related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab (4289) 2021 ·Neurology ·Michael J. Seminerio, Krishna Tangirala, (unknown), Rinat Ariely, Joshua M. Cohen, Karen Carr, Dawn C. Buse	1
3	Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice 2020 ·CHEST Journal ·Michael E. Wechsler, Stephen P. Peters, (unknown), Rinat Ariely, Michael DePietro, Maurice T. Driessen, (unknown), (unknown), Reynold A. Panettieri	24
4	Clinical and Economic Outcomes in Patients with Persistent Asthma Who Attain Healthcare Effectiveness and Data Information Set Measures 2020 ·The Journal of Allergy and Clinical Immunology In Practice ·Giselle Mosnaim, (unknown), Rinat Ariely, Michael DePietro, Miao Jiang, Karthik Ramakrishnan, (unknown), (unknown), Aimee M. Near	2
5	Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma 2020 ·BMJ Open Respiratory Research ·Lulu K. Lee, Karthik Ramakrishnan, Guilherme Safioti, Rinat Ariely, Michael Schätz	46
6	The impact of uncontrolled asthma on quality of life among treated, adherent patients with persistent asthma 2018 ·Journal of Allergy and Clinical Immunology ·Giselle Mosnaim, Lulu K. Lee, Colleen M. Carpinella, Rinat Ariely, (unknown), Njira Lugogo	1
7	Healthcare Resource Utilization and Costs in Patients with Persistent Asthma by Attainment of Healthcare Effectiveness and Data Information Set (HEDIS) Measures 2018 ·Value in Health ·Giselle Mosnaim, Rinat Ariely, Michael DePietro, Aimee M. Near, Huan Huang, (unknown), (unknown)	3
8	A review of the use and effectiveness of digital health technologies in patients with asthma 2018 ·Annals of Allergy Asthma & Immunology ·Elizabeth Unni, (unknown), Rinat Ariely	29
9	Digital Technology Interventions and Their Outcomes in Moderate-to-Severe Asthmatic Patients: A Targeted Literature Review 2018 ·Journal of Allergy and Clinical Immunology ·(unknown), (unknown), Kimberly Ruiz, Rinat Ariely, Giselle Mosnaim	1
10	Real-world Study Characterizing Patients Prior to Receiving Albuterol Multidose Dry Powder Inhaler or Short-acting β2-Agonist Via Pressurized Metered-Dose Inhalers for Asthma and COPD in the United States 2018 ·Journal of Allergy and Clinical Immunology ·(unknown), Emily D. Parker, Rinat Ariely, (unknown), Karthik Ramakrishnan	0
11	Real-world healthcare utilization in asthma patients using albuterol sulfate inhalation aerosol (ProAir® HFA) with and without integrated dose counters 2017 ·Journal of Asthma and Allergy ·Edward Kerwin, Thomas J. Ferro, Rinat Ariely, Debra E. Irwin, (unknown)	1
12	Heart Failure in China: A Review of the Literature 2013 ·Drugs ·Rinat Ariely, Keith E. Evans, Tim Mills	18
13	The burden of preserved ejection fraction heart failure in a real-world Swedish patient population 2013 ·Journal of Medical Economics ·Jan Stålhammar, Lee Stern, (unknown), (unknown), Rohan Parikh, Rinat Ariely, C. Deschaseaux, Gerhard Wikström	18
14	The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands 2011 ·Journal of Medical Economics ·R. Akehurst, (unknown), Rinat Ariely, (unknown), (unknown), (unknown), S. Boonen	24
15	Excess mortality following hip fracture: a systematic epidemiological review breakdown → 2009 ·Osteoporosis International ·Bo Abrahamsen, Tjeerd van Staa, Rinat Ariely, Melvin Olson, Cyrus Cooper	828
16	Persistence, Adherence, and Switch Rates Among Extended-Release and Immediate-Release Overactive Bladder Medications in a Regional Managed Care Plan 2008 ·Journal of Managed Care Pharmacy ·Anna O. D’Souza, Michael J. Smith, Lesley-Ann Miller, Joseph Doyle, Rinat Ariely	182
17	Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB‐SAT‐q) 2008 ·Neurourology and Urodynamics ·Mary Kay Margolis, Kathleen M. Fox, Annamaria Cerulli, Rinat Ariely, Kristijan H. Kahler, Karin S. Coyne	16
18	Long‐term benefits of darifenacin treatment for patient quality of life: Results from a 2‐year extension study 2008 ·Neurourology and Urodynamics ·Peter Dwyer, Con Kelleher, Jay M. Young, François Haab, K. Lheritier, Rinat Ariely, Ursula Ebinger	16
19	MP-10.09: The effect of darifenacin on health-related quality of life in patients with overactive bladder: results from the ABLE study 2007 ·Urology ·M. Chancellor, William S. Aronstein, (unknown), Rinat Ariely, Ursula Ebinger, Farid Kianifard	2
20	Health insurance, access to prescription medicines and health outcomes in children 2005 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Wendy J. Ungar, Rinat Ariely	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact